Why the study?
Does estrogen-induced suppression of hepatic lipase impair the removal of VLDL triglycerides?
Does estrogen-induced suppression of hepatic lipase impair the removal of VLDL triglycerides?
Hepatic lipase does not appear to be a major regulator of VLDL catabolism under physiological circumstances.
Hepatic lipase unlikely major VLDL regulator; leaves open estrogen's physiological lipid effects.
The exact role of the heparin-releasable hepatic endothelial lipase has remained controversial. It has been suggested that it acts in concert with lipoprotein lipase in the step-wise delipidation of triglyceride-rich lipoproteins. On the other hand, there is evidence indicating that high density lipoprotein2 is the preferred substrate for hepatic lipase. Here, it is shown that a moderate (27%) suppression of hepatic lipase activity by estrogen did not impair removal of 3H-labeled very low density lipoproteins (VLDL) triglycerides, suggesting that this enzyme is not a major regulator of VLDL catabolism under physiological circumstances.
No takes yet. Share an insight, caveat, or question.
Tikkanen et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: